Clene Inc.

CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822791

Price chart

Open-market purchases and sales by CLNN insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
May 13, 2026May 11 – May 12, 2026Ugwumba Chidozie10% OwnerSSaleCommon Stock−95.47K$6.3278−$604.13K103.42K−48.0%SEC
May 5, 2026May 1 – May 4, 2026Ugwumba Chidozie10% OwnerSSaleCommon Stock−78.68K$6.7418−$530.44K198.89K−28.3%SEC
Apr 30, 2026Apr 28 – Apr 30, 2026Ugwumba Chidozie10% OwnerSSaleCommon Stock−19.5K$5.7844−$112.78K277.57K−6.6%SEC
Apr 22, 2026Apr 20 – Apr 21, 2026Ugwumba Chidozie10% OwnerSSaleCommon Stock−65.66K$6.1387−$403.08K297.07K−18.1%SEC
Apr 17, 2026Apr 15 – Apr 17, 2026Ugwumba Chidozie10% OwnerSSaleCommon Stock−39.16K$6.4322−$251.9K362.73K−9.7%SEC

The largest institutional positions in CLNN at the end of Q2 2026.

Institutions holding CLNN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Empery Asset Management, LP916,532$5.64M6.52%+916,532New
SCOGGIN MANAGEMENT LP600,000$3.69M0.87%+300,000+100.0%Added
Boxer Capital Management, LLC477,515$2.94M0.22%00.0%Unchanged
Ensign Peak Advisors, Inc348,062$2.14M0.00%+90,190+35.0%Added
VANGUARD CAPITAL MANAGEMENT LLC333,706$2.05M0.00%+25,476+8.3%Added